Bio-Rad Laboratories, Inc. (BIO) Net margin 2016–2025
Bio-Rad Laboratories, Inc. (BIO) net profit margin by fiscal year — reported net income divided by reported revenue.
29.4%FY2025 · since FY2016: 1.3% → 29.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 29.4% | +101.3 pp |
| FY2024 | -71.9% | -48.0 pp |
| FY2023 | -23.9% | +105.6 pp |
| FY2022 | -129.5% | -275.0 pp |
| FY2021 | 145.6% | -4.3 pp |
| FY2020 | 149.8% | +73.8 pp |
| FY2019 | 76.1% | +60.1 pp |
| FY2018 | 16.0% | +10.3 pp |
| FY2017 | 5.7% | +4.4 pp |
| FY2016 | 1.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice